Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Thiamine pyrophosphate enzyme, central domain containing protein | 0.0785 | 0.8648 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0027 | 0.0088 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0088 | 0.0148 |
Brugia malayi | AMP-binding enzyme family protein | 0.0027 | 0.0088 | 0.0072 |
Giardia lamblia | Pyruvate-flavodoxin oxidoreductase | 0.0114 | 0.1077 | 1 |
Loa Loa (eye worm) | ILVBL protein | 0.0475 | 0.5153 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2098 | 0.2826 |
Mycobacterium leprae | PROBABLE BIFUNCTIONAL MENAQUINONE BIOSYNTHESIS PROTEIN MEND : 2-SUCCINYL-6-HYDROXY-2,4-CYCLOHEXADIENE-1-CARBOXYLATE SYNTHASE (SH | 0.0139 | 0.1363 | 0.1489 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0027 | 0.0088 | 0.059 |
Mycobacterium tuberculosis | Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) | 0.0785 | 0.8648 | 1 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0254 | 0.2652 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0469 | 0.5082 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase (beta subunit) | 0.0114 | 0.1077 | 0.1245 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0114 | 0.1077 | 1 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0254 | 0.2652 | 1 |
Mycobacterium ulcerans | acetolactate synthase large subunit IlvB | 0.0449 | 0.4858 | 0.5611 |
Brugia malayi | AMP-binding enzyme family protein | 0.0027 | 0.0088 | 0.0072 |
Echinococcus granulosus | geminin | 0.0205 | 0.2098 | 0.4356 |
Echinococcus granulosus | FTZ F1 alpha | 0.0442 | 0.4784 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0026 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0088 | 0.0148 |
Mycobacterium ulcerans | 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase | 0.0139 | 0.1363 | 0.1564 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0027 | 0.0088 | 0.0088 |
Mycobacterium ulcerans | acetolactate synthase 1 catalytic subunit | 0.0785 | 0.8648 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.002 | 0.0012 | 0.0014 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0027 | 0.0088 | 0.0088 |
Mycobacterium ulcerans | pyruvate or indole-3-pyruvate decarboxylase Pdc | 0.0449 | 0.4858 | 0.5611 |
Schistosoma mansoni | acetolactate synthase | 0.0671 | 0.7359 | 1 |
Schistosoma mansoni | acetolactate synthase | 0.0671 | 0.7359 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0027 | 0.0088 | 0.0088 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0114 | 0.1077 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0254 | 0.2652 | 0.3056 |
Mycobacterium tuberculosis | Probable oxalyl-CoA decarboxylase OxcA | 0.0785 | 0.8648 | 1 |
Treponema pallidum | pyruvate oxidoreductase | 0.0114 | 0.1077 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0088 | 0.0148 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0027 | 0.0088 | 0.0128 |
Mycobacterium ulcerans | hypothetical protein | 0.0785 | 0.8648 | 1 |
Mycobacterium tuberculosis | Acetolactate synthase (large subunit) IlvB1 (acetohydroxy-acid synthase) | 0.0336 | 0.3578 | 0.4137 |
Mycobacterium leprae | Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) | 0.0785 | 0.8648 | 1 |
Entamoeba histolytica | pyruvate:ferredoxin oxidoreductase | 0.0114 | 0.1077 | 1 |
Mycobacterium ulcerans | putative oxalyl-CoA decarboxylase | 0.0785 | 0.8648 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0027 | 0.0088 | 0.0088 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0026 | 0.0016 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2098 | 0.2826 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.0026 | 0.003 |
Brugia malayi | AMP-binding enzyme family protein | 0.0027 | 0.0088 | 0.0072 |
Loa Loa (eye worm) | thiamine pyrophosphate enzyme | 0.045 | 0.4867 | 0.9443 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0027 | 0.0088 | 0.0088 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0114 | 0.1077 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0027 | 0.0088 | 0.059 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0027 | 0.0088 | 0.0128 |
Leishmania major | putative pyruvate/indole-pyruvate carboxylase, putative | 0.0449 | 0.4858 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.002 | 0.0012 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0027 | 0.0088 | 0.0128 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0027 | 0.0088 | 0.0102 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0027 | 0.0088 | 0.059 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0114 | 0.1077 | 1 |
Mycobacterium ulcerans | 2-oxoglutarate ferredoxin oxidoreductase subunit beta | 0.0114 | 0.1077 | 0.1233 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2098 | 0.2078 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0027 | 0.0088 | 0.0088 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0254 | 0.2652 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0469 | 0.5082 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0027 | 0.0088 | 0.0102 |
Onchocerca volvulus | 0.0027 | 0.0088 | 0.5 | |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0114 | 0.1077 | 1 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0114 | 0.1077 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0026 | 0.0027 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0254 | 0.2652 | 1 |
Leishmania major | phosphonopyruvate decarboxylase-like protein | 0.0254 | 0.2652 | 0.5434 |
Mycobacterium ulcerans | acetolactate synthase | 0.0449 | 0.4858 | 0.5611 |
Mycobacterium leprae | PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) | 0.0785 | 0.8648 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.0026 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0027 | 0.0088 | 0.0088 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0046 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.2909 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.